DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Innohep (Tinzaparin) - Incorrect Drug Administration Duration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Incorrect Drug Administration Duration (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Innohep (Tinzaparin) where reactions include incorrect drug administration duration. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Innohep side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 65 year old male

Reactions: Lymphadenopathy, Incorrect Drug Administration Duration, Spinal Compression Fracture, Dyspepsia, Tachycardia, Underdose, Lower Urinary Tract Symptoms, Calculus Urinary

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 255 mg days 1 and 2 of each 28 day cycle,intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-02

Innohep
    Dosage: 14000 units daily,subcutaneous ; 0.6 mg (1 in 1 d),subcutaneous ; (1 in 1 d),subcutaneous
    Indication: Pulmonary Embolism
    Start date: 2011-05-09
    End date: 2012-04-05

Innohep
    Dosage: 14000 units daily,subcutaneous ; 0.6 mg (1 in 1 d),subcutaneous ; (1 in 1 d),subcutaneous
    Indication: Pulmonary Embolism
    Start date: 2011-06-10
    End date: 2011-06-18

Innohep
    Dosage: 14000 units daily,subcutaneous ; 0.6 mg (1 in 1 d),subcutaneous ; (1 in 1 d),subcutaneous
    Indication: Pulmonary Embolism
    Start date: 2011-06-20

Prednisolone
    Dosage: 10 mg (1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Rituximab (Rituximab)
    Dosage: 800 mg day 1 of each 28 cycle,intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-02-02

Other drugs received by patient: Valacyclovir; Allopurinol; Tamsulosin HCL; Esomeprazole Magnesium; Bisoprolol Fumarate



Possible Innohep side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-21

Patient: 63 year old male

Reactions: Phlebitis, Incorrect Drug Administration Duration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Innohep

Other drugs received by patient: Inegy (Inegy); Naftidrofuryl (Naftidrofuryl); Cozaar; Kardegic (Acetylsalicylate Lysine)



Possible Innohep side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-04

Patient:

Reactions: Off Label Use, Incorrect Drug Administration Duration, Osteoporosis, Haemorrhage, Heparin-Induced Thrombocytopenia

Drug(s) suspected as cause:
Innohep



Possible Innohep side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24

Patient: 73 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Agitation, Incorrect Drug Administration Duration, Restlessness, Feeling Abnormal, Muscle Tightness, Discomfort

Drug(s) suspected as cause:
Innohep

Other drugs received by patient: Lidocaine; Venofer (Saccharate Iron Oxide)



Possible Innohep side effects in 73 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-16

Patient: 73 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Agitation, Incorrect Drug Administration Duration, Restlessness, Muscle Tightness, Feeling Abnormal, Discomfort

Drug(s) suspected as cause:
Innohep

Other drugs received by patient: Venofer; Lidocaine



Possible Innohep side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-26

Patient: 51 year old female

Reactions: Haemoglobin Decreased, Bronchial Neoplasm, Off Label Use, Incorrect Drug Administration Duration, Haemoptysis, Neoplasm Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Innohep
    Dosage: 0.5 ml (1 in 1 d),subcutaneous
    Indication: Superior Vena Cava Syndrome
    Start date: 2011-04-28
    End date: 2011-06-11

Tarceva
    Dosage: 150 mg,oral
    Administration route: Oral
    Indication: Lung Adenocarcinoma
    Start date: 2011-04-22
    End date: 2011-06-11

Other drugs received by patient: Spiriva; Mucomyst; Augmentin '125'; Protifar (Protifar); Fluticasone Propionate / Salmeterol; Nexium IV; Amoxicillini (Amoxi-Clavulanico); Tolexine (Doxycycline); Spasfon (Spasfon / 00765801 / ); Celluvisc (Carmellose Sodium)



Possible Innohep side effects in 59 year old female

Reported by a individual with unspecified qualification from Spain on 2012-03-07

Patient: 59 year old female

Reactions: Incorrect Drug Administration Duration, Hiatus Hernia, Diarrhoea, Anaemia, Upper Gastrointestinal Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Innohep
    Dosage: (1 in 1 d),sc
    Indication: Prophylaxis
    Start date: 2011-02-01
    End date: 2011-11-09

Yervoy
    Dosage: (1 total),intravenous (not otherwise specified)
    Indication: Metastatic Malignant Melanoma
    Start date: 2011-10-07
    End date: 2011-10-28

Other drugs received by patient: Pariet 10 MG Comprimidos Gastrorresistentes, 28 Comprimidos; Atrorvastatina (Atorvastatin Calcium); Lyrica 75mg 100 Capsulas Duras



Possible Innohep side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-13

Patient: male

Reactions: Off Label Use, Thrombosis, Incorrect Drug Administration Duration, Overdose, Disease Recurrence, Medication Error

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Innohep



Possible Innohep side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-09

Patient: 60 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Incorrect Drug Administration Duration, Oedema Peripheral, Underdose, Drug Prescribing Error

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Innohep
    Dosage: preventive dosage,subcutaneous ; 10000 iu,subcutaneous
    Indication: Deep Vein Thrombosis
    Start date: 2011-12-14
    End date: 2011-12-30

Innohep
    Dosage: preventive dosage,subcutaneous ; 10000 iu,subcutaneous
    Indication: Deep Vein Thrombosis
    Start date: 2011-12-30



Possible Innohep side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-12-27

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Off Label Use, Incorrect Drug Administration Duration, Needle Issue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Innohep



Possible Innohep side effects in 81 year old female

Reported by a physician from France on 2011-11-22

Patient: 81 year old female

Reactions: Incorrect Drug Administration Duration, Intentional Drug Misuse, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Innohep



Possible Innohep side effects in 81 year old female

Reported by a physician from France on 2011-11-17

Patient: 81 year old female

Reactions: Haemoglobin Decreased, Incorrect Drug Administration Duration, Injection Site Haematoma, Drug Administration Error, Bite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Innohep



Possible Innohep side effects in 87 year old female

Reported by a physician from France on 2011-10-18

Patient: 87 year old female, weighing 73.0 kg (160.6 pounds)

Reactions: Incorrect Drug Administration Duration, Creatinine Renal Clearance Decreased, Contusion, Haemorrhage, Hyperkalaemia, Anaemia, Haematoma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg, oral
    Administration route: Oral
    Indication: Cardiac Failure

Innohep
    Dosage: subcutaneous; subcutaneous
    Indication: Deep Vein Thrombosis
    Start date: 2011-06-16

Innohep
    Dosage: subcutaneous; subcutaneous
    Indication: Deep Vein Thrombosis
    Start date: 2011-06-29

Lasilix (Furosemide) (40 Milligram, Tablet)
    Dosage: 2 in 1 d, oral
    Administration route: Oral
    Indication: Cardiac Failure

Other drugs received by patient: Doliprane (Paraceamol); Speciafoldine (Folic Acid); Eupantol (Pantoprazole Sodium Sesquihydrate); Levothyroxine Sodium; Lexomol (Bromazepam)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017